Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
8
×
gene therapy
8
×
life sciences
national
national blog main
national top stories
new york top stories
san francisco top stories
biotech
new york blog main
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
clinical trials
glaxosmithkline
amgen
fda
medicare
merck
zolgensma
abbvie
bristol-myers squibb
celgene
What
bio
roundup
drug
new
patients
cancer
crispr
fda
healthcare
immunotherapy
ipo
moves
news
remains
talk
therapy
acquisitions
advanced
albert
allogene
america
approval
approved
arrival
atrophy
august
award
becker
biggest
billions
biogen
biogen’s
biopharmaceutical
biotech
bourla
busy
ceo
companies
company
continues
Language
unset
unknown
Current search:
biogen
×
" gene therapy "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More